Breast cancer is a heterogeneous disease and, based on the molecular profile, can be classified in four main subtypes: luminal A and B, HER2-enriched, and basal-like (Sorlie et al., 2003; Heng et al., 2017). Here, ERBB2 is linked to breast carcinoma.